Peer Review, Workforce

New CEOs at Axovant, Destiny and Organovo mark a busy week for the biotech jobs scene

Peer Review is the weekly biopharma jobs report from Endpoints News.

Neil Bodick, Flexion

→ Musculoskeletal company Flexion Therapeutics $FLXN said co-founder Neil Bodick will transition to CSO from CMO. Yamo Deniz becomes CMO. Deniz was VP and global head of medical for rare diseases at the Genzyme unit of Sanofi.

→ Rare diseases play PTC Therapeutics $PTCT said CFO Shane Kovacs will leave the company in mid-May. PTC is seeking a replacement.

→ Cell therapy concern Vericel $VCEL named Michael Halpin SVP of quality and regulatory affairs. He was VP and North American region regulatory head at Genzyme.

→ Hemophilia company Bioverativ $BIVV named Tim Harris EVP of R&D. He was a partner at SV Life Sciences.

Michael Gutch, Entasis

→ Anti-infective firm Entasis Therapeutics named Mike Gutch CFO and CBO. He was executive director of corporate development at AstraZeneca.

Lorianne Masuoka, Marinus

→ Lorianne Masuoka joins Marinus Pharmaceuticals as their new CMO. She’s a neurologist who held chief medical roles at InVivo, Cubist, and Nektar previously.

→ Taylor Crouch is replacing Keith Murphy as CEO of San Diego-based Organovo $ONVO, a developer of human tissue models. Crouch was the CEO of eStudySite, and earlier in his career was senior vice president of marketing and sales at Parexel.

→ Oxford’s e-Therapeutics appointed Raymond Barlow as CEO. Barlow was previously executive director of corporate development at Amgen.

→ Destiny Pharma, an anti-microbial biotech, named Neil Clark as CEO. Bill Love, the previous CEO and scientific founder, is now the CSO.

→ David Hung is the new CEO of Axovant $AXON. He comes by way of Medivation, where as co-founder and CEO he led the company to a $14.3 billion acquisition by Pfizer.

The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 41,900+ biopharma pros who read Endpoints News by email every day.

Free Subscription

Head of Business Development
Wren Therapeutics Boston, MA
Life Sciences Venture Professional
Northpond Ventures Washington, DC
Senior Drug Discovery Oncologist
Schrödinger New York, NY

Visit Endpoints Careers ->